Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 1201-1206

  Jackson, Mitchell A ^a   Burrell, Kim ^b   Gaddie, Ian B ^c   Richardson, Shana D ^d  

^a Jacksoneye   (United States)

^b Centennial Eye Associates   (United States)

^c Gaddie Eye Centers   (United States)

^d OCuSOFT   (United States)

Author keywords

Essential fatty acids; Omega 3; Omega 6; TBUT; Tear breakup time

Indexed keywords

CYCLOSPORIN A; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TEARS AGAIN HYDRATE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRY EYE; FOLLOW UP; HISTOCHEMISTRY; HUMAN; LACRIMATION; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRESCRIPTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 81055140873     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/opth.s22647     Document Type: Article

References (20)

1. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Work Shop (2007). Ocul Surf. 2007;5:93-107.
2. Lemp MA. Advances in understanding and managing dry eye disease. Am J Ophthalmol 2008;146:350-356.
3. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25: 900-907.
4. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye Work Shop (2007). Ocul Surf. 2007;5:163-178.
5. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 2000;107:631-639.
6. Rosenberg ES, Asbell PA. Essential fatty acids in the treatment of dry eye. Ocul Surf. 2010;8:18-28.
7. SanGiovanni JP, Chew EY, Clemons TE, et al; and the Age-Related Eye Disease Study Research Group. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol. 2007;125:671-679.
8. Miljanović B, Trivedi KA, Dana MR, et al. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr. 2005;82:887-893.
9. Cakiner-Egilmez T. Omega-3 fatty acids and the eye. Insight. 2008;33: 20-25.
10. Roncone M, Bartlett H, Eperjesi F. Essential fatty acids for dry eye: a review. Cont Lens Anterior Eye. 2010;33:49-54.
11. Pinheiro MN Jr, dos Santos PM, dos Santos RC, et al. Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjögren's syndrome patients. Arq Bras Oftalmol. 2007;70:649-655.
12. Wojtowicz JC, Butovich I, Uchiyama E, et al. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea. 2011;30:308-314.
13. Schnebelen C, Viau S, Grégoire S, et al. Nutrition for the eye: Different susceptibility of the retina and the lacrimal gland to dietary omega-6 and omega-3 polyunsaturated fatty acid incorporation. Ophthalmic Res. 2009;41:216-224.
14. Viau S, Maire MA, Pasquis B, et al. Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch Clin Exp Ophthalmol. 2009;247:1039-1050.
15. Belch JJ, Hill A. Evening primrose oil and borage oil in rheumatologic conditions. Am J Clin Nutr. 2000;71(Suppl 1):S352-S356.
16. Kokke KH, Morris JA, Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye. 2008;31:141-146.
17. Pinna A, Piccinini P, Carta F. Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction. Cornea. 2007;26:260-264.
18. Aragona P, Bucolo C, Spinella R, et al. Systemic omega-6 fatty acid treatment and pge1 tear content in Sjögren's syndrome patients. Invest Ophthalmol Vis Sci. 2005;46:4474-4479.
19. Barabino S, Rolando M, Camicione P, et al. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea. 2003;22:97-101.
20. Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51:6125-6130.